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Cigarette smoke and chewing 
tobacco alter expression of 
different sets of miRNAs in oral 
keratinocytes
Mohd Younis Bhat1,2, Jayshree Advani1,3, Pavithra Rajagopalan1,4, Krishna Patel  1,2, 
Vishalakshi Nanjappa1, Hitendra S. Solanki1,4, Arun H. Patil1,4,5, Firdous A. Bhat1,2,  
Premendu P. Mathur4, Bipin Nair2, T. S. Keshava Prasad  1,5, Joseph A. Califano6,  
David Sidransky7, Harsha Gowda  1 & Aditi Chatterjee1
Carcinogenic effect of tobacco in oral cancer is through chewing and/or smoking. Significant differences 
exist in development of oral cancer between tobacco users and non-users. However, molecular 
alterations induced by different forms of tobacco are yet to be fully elucidated. We developed 
cellular models of chronic exposure to chewing tobacco and cigarette smoke using immortalized oral 
keratinocytes. Chronic exposure to tobacco resulted in increased cell scattering and invasiveness 
in immortalized oral keratinocytes. miRNA sequencing using Illumina HiSeq 2500 resulted in the 
identification of 10 significantly dysregulated miRNAs (4 fold; p ≤ 0.05) in chewing tobacco treated 
cells and 6 in cigarette smoke exposed cells. We integrated this data with global proteomic data and 
identified 36 protein targets that showed inverse expression pattern in chewing tobacco treated cells 
and 16 protein targets that showed inverse expression in smoke exposed cells. In addition, we identified 
6 novel miRNAs in chewing tobacco treated cells and 18 novel miRNAs in smoke exposed cells. 
Integrative analysis of dysregulated miRNAs and their targets indicates that signaling mechanisms 
leading to oncogenic transformation are distinct between both forms of tobacco. Our study 
demonstrates alterations in miRNA expression in oral cells in response to two frequently used forms of 
tobacco.
Oral squamous cell carcinoma (OSCC) is one of the most common cancers worldwide and remains the most 
common malignancy of the head and neck cancers. Tobacco use, alcohol consumption and human papilloma 
virus (HPV) 16/18 have been identified as the main risk factors for the initiation and progression of OSCC1. 
Tobacco is mainly consumed worldwide in the form of manufactured cigarettes. Tobacco is also consumed in 
the form of smokeless tobacco, especially chewing tobacco in South-East Asian countries2. Despite being one 
of the most common cancers in India, molecular alterations in oral cancer development in tobacco chewers and 
smokers is not well understood.
MicroRNAs have been established as key regulators of oncogenic potential in cells. Alterations at the genetic 
and epigenetic levels in the complex enzymatic machinery involved in miRNA biogenesis can result in aberrant 
miRNA expression3. Post-transcriptional regulation of gene expression by miRNAs has an influence on multi-
ple pathways, including those involved in cellular transformation and proliferation4. miRNAs function as either 
oncogenes or tumor suppressors, playing crucial roles in tumorigenesis, tumor invasion and metastasis5. In recent 
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years multiple studies have revealed the altered expression of miRNAs which play a role in the development and 
progression of diverse cancers including oral squamous cell carcinoma6–8. Increased expression of microRNAs 
including miR-155 and miR-23a, have been observed in oral cancer patients that are tobacco chewers compared 
to non-chewers9,10. Fanconi anemia complementation group G protein (FANCG) is a miR-23a target with a role 
in DNA double strand break repair pathway. Decreased expression of FANCG in normal oral fibroblasts contrib-
utes to the development of carcinogenesis on treatment with areca nut10. In contrast, microRNAs such as miR-145 
are found to be significantly downregulated upon cigarette smoke condensate treatment in oral fibroblasts while 
its target protein MMP-2 is overexpressed which plays a key role in perturbation of stromal-epithelial communi-
cation and promotes pro-tumorogenic interactions11. Similarly, a decrease in miR-101-3p and a corresponding 
increase in expression levels of its target protein COX2 was observed in an esophageal non-tumorigenic cell 
line upon treatment with cigarette smoke condensate thereby facilitating cell transformation and cancer devel-
opment12. Downregulation of miR-200c levels in human bronchial epithelial cells with increased expression of 
IL-6 and activation of nuclear factor-κB (NF-κB) pathway by cigarette smoke extract is also shown to regulate 
epithelial-mesenchymal transition and carcinogenesis13.
Taken together, these studies indicate that molecular mechanisms for cellular transformation may vary 
depending upon the form of tobacco used. Till date no study has systematically investigated the differences 
in molecular alterations induced in oral cells upon exposure to different forms of tobacco. To achieve this, we 
developed two cellular models where immortalized, oral keratinocytes (OKF6/TERT1) were chronically treated 
with either chewing tobacco or exposed to cigarette smoke for a period of six months. To understand specific 
molecular alterations brought about by each form of tobacco, we performed miRNA sequencing of oral keratino-
cytes chronically treated with chewing tobacco/cigarette smoke. miRNA dysregulation is in turn known to affect 
expression of their target proteins leading to diverse functional consequences. Hence, in addition to studying 
miRNA dysregulation, we have investigated proteomic alterations associated with exposure to these two forms 
of tobacco.
We observed that chronic treatment of, immortalized oral keratinocytes with either chewing tobacco extract 
or cigarette smoke condensate affected expression of distinct set of miRNAs and their corresponding protein 
targets.
Results
Chronic exposure to chewing tobacco and cigarette smoke results in phenotypic changes in oral cells. 
In this study, we chronically treated immortalized oral keratinocytes (OKF6/TERT1) with chewing tobacco 
extract and cigarette smoke condensate to model the effects of tobacco chewing and smoking in oral cancer. 
We observed an increase in proliferative capability of both OKF6/TERT1-Tobacco and OKF6/TERT1-Smoke 
cells compared to OKF6/TERT1-Parental cells (Fig. 1a). Both tobacco treated and smoke exposed cells displayed 
increased cell scattering phenomena (Fig. 1b) which is one of the features of cancer cell phenotype. We also 
observed an increase in the invasive ability of oral keratinocytes upon chronic treatment with chewing tobacco/
cigarette smoke (Fig. 1c,d). We also observed change in expression levels of markers associated with EMT in 
both chewing tobacco treated and cigarette smoke exposed cells compared to parental cells.There was a decrease 
in expression of E-Cadherin (processed band, lower) and a increase in vimentin expression in OKF6/TERT1-
Tobacco and OKF6/TERT1-Smoke cells compared to OKF6/TERT1-Parental cells (Fig. 1e). To further elucidate 
the molecular alterations imparted by each type of insult, we studied miRNA and proteomic expression pattern 
in these cells compared to untreated parental cells.
Chronic exposure to chewing tobacco/cigarette smoke results in altered miRNA expression in oral 
keratinocytes. We carried out deep small RNA sequencing on Illumina HiSeq 2500 platform. We acquired 
31 million reads for untreated control cells, 56 million reads for tobacco treated cells and 47 million reads for 
smoke exposed cells. A schematic representation of the workflow is provided in Supplementary Fig. S1. miRNA 
expression analysis resulted in identification of 427 and 456 miRNAs in chewing tobacco treated and cigarette 
smoke exposed oral keratinocytes, respectively (Fig. 2). Amongst these 10 miRNAs were significantly dysregu-
lated (≥4 fold, p ≤ 0.05) in chewing tobacco treated cells and 6 miRNAs were significantly dysregulated in ciga-
rette smoke exposed cells (Fig. 3a,b). A complete list of miRNAs along with corresponding fold-changes in OKF6/
TERT1-Tobacco and OKF6/TERT1-Smoke cells are provided in Supplementary Tables S1A,B.
Altered protein expression pattern associated with chronic exposure to chewing tobacco/cigarette 
smoke in oral keratinocytes. We employed a TMT-based proteomic approach to investigate global pro-
teomic alterations in response to chewing tobacco/cigarette smoke treatment. LC-MS - based quantitative pro-
teomics led to quantification of 2,821 and 5,342 proteins in OKF6/TERT1-Tobacco and OKF6/TERT1-Smoke 
cells, respectively. The proteomics workflow employed to carry out this investigation is outlined in Supplementary 
Fig. S1. Amongst the 311 significantly dysregulated proteins in OKF6/TERT1-Tobacco, 197 were overexpressed 
(≥1.5-fold, p-value ≤ 0.05) and 114 proteins were downregulated (≤0.6-fold, p-value ≤ 0.05). In case of OKF6/
TERT1-Smoke cells, 229 proteins were overexpressed (≥1.5-fold, p-value ≤ 0.05) and 159 were downregulated 
(≤0.6-fold, p-value ≤ 0.05). The complete list of identified proteins and peptides is provided in Supplementary 
Tables S2A,B.
Correlation of miRNAs with protein expression. Since we observed altered expression of both miRNAs 
and proteins in response to two forms of tobacco, we compared expression pattern using experimentally proven 
targets of miRNAs from miRTarBase14. We fetched targets of 10 significantly dysregulated miRNAs identified in 
OKF6/TERT1-Tobacco cells from miRTarBase. There were 293 proteins that were identified in our proteomics 
data (Supplementary Table S3A). In case of OKF6/TERT1-Smoke cells, we identified 218 protein targets in our 
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proteomic data for the 6 significantly dysregulated miRNAs (Supplementary Table S3B). To understand the cor-
relation between significantly dysregulated miRNAs and their target proteins, miRNA-gene interaction network 
analysis was generated using miRNet tool15. The 10 miRNAs significantly dysregulated in OKF6/TERT1-Tobacco 
cells showed directional relationship with 36 target proteins identified in proteomics data (Fig. 4a). Reverse tran-
scriptase PCR-based validation of some of the targets is provided in Supplementary Fig. S2A. Our proteomics 
data revealed downregulation of superoxidase dismutase, SOD2, in tobacco treated OKF6/TERT1 cells and in 
conjunction with this we observed a significant decrease in SOD2 expression in OKF6/TERT1-Tobacco cells 
compared to OKF6/TERT1-Parental cells (Supplementary Fig. S2A, see Western panel). The 6 miRNAs which 
were significantly dysregulated in OKF6/TERT1-Smoke cells showed directional relationship with 16 target 
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Figure 1. Chronic treatment of oral keratinocytes with chewing tobacco and cigarette smoke. OKF6/TERT1-
Parental, OKF6/TERT1-Tobacco and OKF6/TERT1-Smoke cells were assessed for (a) cellular proliferation 
(b) colony formation (c,d) invasive ability and (e) epithelial–mesenchymal transition (EMT) using Western 
blotting. β-actin was used as a loading control.
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proteins (Fig. 4b). Expression of some of these targets was validated using reverse transcriptase PCR and is pro-
vided in Supplementary Fig. S2B. We observed a 1.8 fold increase in TGFB2 expression in smoke exposed OKF6/
TERT1 cells in our proteomics data and this increase in expression was confirmed by Western blot analysis of 
OKF6/TERT1-Smoke cells compared to OKF6/TERT1-Parental cells as depicted in Supplementary Fig. S2B (see 
Western panel). Significantly dysregulated miRNAs and their corresponding targets which showed a directional 
relationship are highlighted (miRNAs and protein targets which are upregulated are highlighted in red and miR-
NAs and protein targets which are downregulated are in blue color) in Supplementary Table S3A,B.
Figure 2. Bioinformatics workflow. Pipeline depicting the analysis of dysregulated miRNA in OKF6/TERT1-
Tobacco and OKF6/TERT1-Smoke cells and novel miRNA identification.
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Figure 3. A volcano plot showing distribution of miRNAs in (a) OKF6/TERT1- Tobacco cells (b) OKF6/
TERT1-Smoke cells. The red dots represent significantly dysregulated miRNAs (p-value ≤ 0.05).
www.nature.com/scientificreports/
5SCientifiC RepoRts |  (2018) 8:7040  | DOI:10.1038/s41598-018-25498-2
Bioinformatics analysis. We used STITCH tool (version 5.0)16 to analyse the protein-protein interaction 
of targets which showed inverse relationship with their corresponding miRNAs in tobacco and smoke exposed 
cells. Functional enrichment analysis was performed for proteins which were overexpressed and targeted by sig-
nificantly downregulated miRNAs in tobacco treated cells. This revealed enrichment of spliceosome-associated 
proteins that have a major role in processing of pre-mRNA/splicing into its mature forms (Fig. 5a). Similarly pro-
teins which were overexpressed and are targeted by the significantly downregulated miRNAs in smoke exposed 
cells, showed enrichment of proteins which play an essential role in chromatin remodelling and transcriptional 
regulation (Fig. 5b).
Novel miRNA analysis. Small RNA-Seq datasets for OKF6/TERT1-Parental, OKF6/TERT1-Tobacco and 
OKF6/TERT1-Smoke cells were analyzed for novel miRNAs using miRDeep217. Novel miRNA with miRDeep2 
score ≥1, ≥8 reads supporting mature miRNA, and ≥2 reads supporting loop/star sequence were filtered to 
acquire high confidence list. This led us to identify 3 novel miRNAs in OKF6/TERT1-Parental, 6 novel miR-
NAs in OKF6/TERT1-Tobacco and 18 novel miRNAs in OKF6/TERT1-Smoke cells. The genomic locations of 
the novel miRNAs are provided in Supplementary Tables S4A–C. The secondary structures of these novel miR-
NAs are depicted in Supplementary Fig. S3A–C, Supplementary Fig. S4A–F and Supplementary Fig. S5A–R, 
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respectively. Amongst the novel miRNAs, two miRNAs were common between OKF6/TERT1-Tobacco and 
OKF6/TERT1-Smoke cells, but these were not identified in OKF6/TERT1-Parental cells (Fig. 6). To compare their 
expression pattern, we normalized read support of each novel miRNA with number of unique reads (length ≥18) 
from their respective sequence library. Novel miRNA NM-OKF6-ST-01-3p in tobacco treated cells showed a 
relatively higher expression with 1,726 reads compared to smoke exposed cells with 47 reads. Conversely, miRNA 
NM-OKF6-ST-02-5p showed higher expression in smoke exposed cells with 532 reads compared to tobacco 
treated cells with 53 reads.
Discussion
Chewing tobacco is one of the known risk factors associated with oral cancer18. This is a common practice in 
India compared to the the western world2. Therefore, limited molecular level investigations have been carried 
out on the effect of chewing tobacco compared to tobacco smoking. In this study, using cellular models, we have 
systematically studied the alterations in miRNA expression and their targets in response to both chewing tobacco 
and cigarette smoke.
During the last few decades, miRNAs have emerged as one of the key regulators of cellular processes ranging 
from cell cycle regulation, differentiation, cell migration and apoptosis19. Their discovery has initiated a revo-
lutionary change in cancer research, making them one of the important parameters to be elucidated in cancer. 
We identified several miRNAs previously reported to be dysregulated in oral cancer substantiating our data in 
both chewing tobacco treated and cigarette smoke exposed oral cells. We observed significant upregulation of 
miR-31-5p in OKF6/TERT1-Tobacco cells. Association of miR-31-5p dysregulation has been shown to result in 
initiation and progression of oral leukoplakia to full blown OSCC20,21. We also observed overexpression of miR-
29c-3p and miR-146a-5p in chewing tobacco treated cells. High expression of miR-29c-3p has been reported in 
aggressive oral tongue tumours and in OSCC22,23. Also, miR-29c-3p was found to be upregulated with decreased 
expression level of its target protein PTX3 in meningiomas24. The role of miR-146a-5p remains ambiguous in oral 
cancer related studies. Loss or decreased expression of miR-146a-5p was found to be associated with aggressive 
behaviour in oral squamous cell carcinoma25. Contrary to this, Hung et al., reported that miR-146a expression 
contributes to oral carcinogenesis by targeting the IRAK1, TRAF6 and NUMB genes. The plasma levels of miR-
146a in OSCC patients were also significantly higher as compared to control groups26. miR-1266-5p has been 
reported as an oncomiR and is reported to be over expressed in HNSCC patients who are users of alcohol27. 
Similarly, miR-196b-5p is reported to be overexpressed in oesophageal adenocarcinoma, gastric and oral cancer 
in smokers28–30. In contrary to this data we observed downregulation of miR-1266-5p and miR-196b-5p in oral 
keratinocytes chronically treated with tobacco, indicating that expression profile of miRNAs possibly depends 
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on the type of insult which induces carcinoma. Interestingly, downregulation of miR-196b has been associated 
with increase in EMT31. This is in concordance with our cellular assays where we observed an increase in pro-
tein markers associated with EMT in tobacco treated cells. Similarly we observed increased expression of miR-
193a-5p in the tobacco treated cells, where as previous studies have shown miR-193a-5p is silenced by DNA 
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hypermethylation in HNSCC and OSCC in smokers, indicating that the expression profile of miRNAs in oral 
cells may depend on the form of tobacco used32.We identified several miRNAs in chewing tobacco treated oral 
keratinocytes which are reported to be dysregulated in other cancer types but not in OSCC. miR-4454 and miR-
33b-5p were seen to be significantly overexpressed in chewing tobacco treated cells and have been previously 
reported to be highly expressed in bladder cancer patients33,34. Decreased expression of miR-1304-3p is reported 
in non-small cell lung carcinoma35.
Regulation of gene expression at the post-transcriptional level by miRNAs influences a wide variety of path-
ways, including oncogenic pathways. Since miRNAs are known to be involved in tumorigenesis by inhibiting 
target proteins, we also studied the expression profile of proteins targeted by significantly dysregulated miR-
NAs. miR-1304-3p identified as downregulated and its target protein ras GTPase-activating protein-binding pro-
tein 1 (G3BP1) was found to be upregulated (1.52 fold; p-value ≤ 0.05) in tobacco treated cells. Overexpression 
of G3BP1 has been reported in multiple cancers including oral squamous cell carcinoma36–38. Knockdown of 
G3BP1 induced programmed cell death and decreased cell viability in OSCC cell lines39. Chromatin remodelling 
complex protein, SMARCE1 (a target of miR-1266-5p) which was overexpressed (1.64 fold; p-value ≤ 0.05) in 
tobacco treated cells has been associated with both breast cancer invasion and metastasis in ovarian cell carci-
noma40–42. We observed downregulation of signal transducer and activator of transcription 1, (STAT1) (0.35 fold; 
p-value ≤ 0.05) in OKF6/TERT1-Tobacco cells. STAT1 is a target protein of miR-146a-5p (significantly upregu-
lated in tobacco treated cells) and is reported to be downregulated due to promoter methylation in HNSCC. Its 
exogenous expression in HNSCC cell lines led to growth inhibition and increased chemotherapy-induced apop-
tosis43. GNB2L1 (RACK1 – target of miR-196b-5p) has been reported to promote progression of oral squamous 
cell carcinoma via the AKT/mTOR pathway and induces OSCC cell migration; invasion and metastasis44. We 
observed a 1.55 fold (p-value ≤ 0.05) overexpression of GNB2L1 and downregulation of miR-196b-5p in the cells 
chronically treated with chewing tobacco.
We identified significant downregulation of members of miR-200 family in OKF6/TERT1 cells chronically 
exposed to cigarette smoke. Multiple miR-200 members including miR-200a, miR-200b and miR-200c have been 
previously reported to be downregulated in head and neck cancers45–48. In addition, we also observed decrease in 
expression of miR-205 in smoke exposed cells. Loss of miR-205 expression has been associated with poor progno-
sis of head and neck cancer patients49,50. miR-200 family target protein, fibronectin 1, FN1 which was seen to be 
1.6 fold overexpressed in OKF6/TERT1-Smoke cells is reported to be overexpressed in salivary gland carcinoma 
and in OSCC patients with lymph node metastasis51,52. Transforming growth factor-β 2, TGFB2 which is known 
to be overexpressed in multiple cancers including OSCC and induces malignancy was 1.8 fold overexpressed 
(p-value ≤ 0.05) in our data. It is targeted by miR-141-3p which was downregulated in our data. It is suggested that 
the ability of OSCC cells to secrete TGF-β2 could contribute to clinical progression by maintaining a microenvi-
ronment conducive for tumor growth and proliferation53,54. In addition to the proteins discussed above we have 
identified a number of proteins which were overexpressed in smoke exposed cells and inversely correlated to their 
respective miRNAs, but have not been reported in literature in the context of oral cancer. H2A histone family mem-
ber Z, H2AFZ (1.7 fold overexpressed; p-value ≤ 0.05) which showed inverse relationship with miR-200a-3p and 
miR-141-3p has been reported to be highly expressed in breast, prostate, bladder and hepatocellular cancers and 
enhances tumorigenesis by accelerating cell cycle and epithelial to mesenchymal transition55–57. We also observed 
overexpression of a number of protein targets of miR-205-5p in smoke exposed cells. Reports indicate high expres-
sion of squalene monooxygenase (SQLE) in breast and hepatocellular carcinoma and plays a key role in induction 
of epithelial-mesenchymal transition in esophageal carcinoma58,59. Hypomethylation of inositol monophosphatase 
domain containing 1 (IMPAD1) has been associated with its overexpression in breast carcinoma60. Sharieha et al., 
reported upregulation of transmembrane 9 superfamily member 2 (TM9SF2) in breast carcinoma cells when com-
pared to normal cells which in turn promoted growth and survival of carcinoma cells. Laminin B1 (LMNB1) (1.6 
fold overexpressed; p-value ≤ 0.05) which is targeted by both miR-200b-3p and miR-200c-3p (downregulated in 
smoke exposed cells) is reported to be overexpressed in colorectal and hepatocellular carcinoma. It is also observed 
that its elevation in plasma could be used for early detection of hepatocellular carcinoma61,62. Loss of expression of 
miR-200 family plays a crucial role in the repression of E-Cadherin and promotes EMT13,63. We observed change 
in expression of markers associated with EMT progression in smoke exposed oral cells.
Our data indicates dysregulation of proteins which play a key role in mRNA processing and splicing in tobacco 
treated cells. We and others have shown in the past that aberrant activation of spliceosome complex-associated 
proteins has been shown to influence cellular transformation leading to development of cancer, including 
HNSCC64,65.Our proteomic data shows significant overexpression of splicing proteins serine and arginine 
rich splicing factor 2 (SRSF2) and splicing factor 3b (SF3B1) (1.9 and 1.5 fold overexpressed respectively; 
p-value ≤ 0.05) in tobacco treated cells. Increased expression of SRSF2 is associated with progression and poor 
prognosis in human hepatocellular carcinoma66. mRNA processing/splicing and chromosome remodelling were 
thought to traverse different paths but studies are revealing that there is a strong cross talk between the two in 
executing their vital processes67. Mutations in several components of chromatin remodelling complex, SWI/SNF 
have been linked to malignant transformation and progression of cancer. SWI/SNF-related matrix-associated 
actin-dependent regulator of chromatin subfamily E member 1 (SMARCE1) is known to play an essential role in 
breast cancer metastasis by protecting cells against anoikis through the HIF1A/PTK2 pathway41. We observed a 
significant increased expression of SMARCE1 in tobacco treated oral cells.
In contrast, we have observed increased expression of proteins responsible for transcriptional regulation and 
nucleosome assembly in smoke exposed oral keratinocytes. Acrolein which is a major component of cigarette 
smoke, forms adducts with histone proteins and specifically inhibits appropriate covalent modifications of cyto-
solic histone H3 and H4 by inhibiting acetylation and results in aberrant nucleosome assembly. Electrophiles, 
such as metabolically activated polycyclic aromatic hydrocarbons and alkylating agents are assumed to have the 
same effect on nucleosome assembly68. DNA methyltransferase 1 (DNMT1) which is reported to be overexpressed 
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in response to cigarette smoke in non-small cell lung carcinoma and was found significantly overexpressed (1.9 
fold overexpressed; p-value ≤ 0.05) in smoke exposed cells69. Overexpression of DNMT1 in lung cancer is asso-
ciated with increased expression of histone deacetylases (HDACs) which increases the stability of DNMT1 and 
in turn stimulates cancer progression70. Sp1 transcription factor (Sp1) which plays a role in multiple cellular 
processes including chromatin remodelling is significantly upregulated in the smoke exposed cells. Nicotine pro-
motes lung cancer proliferation via α7-nicotinic acetylcholine receptor (α7-nAChR). It has been unveiled that 
nicotine induces binding of Sp1 on α7-nAChR promoter, leading to transcriptional activation of α7-nAChR in 
lung cancer, which in turn facilitates tumor growth and progression71.
To the best of our knowledge, this is the first global study employing an integrative analysis approach on 
high-throughput proteomic and miRNA profiling data to investigate the molecular alterations brought about 
in immortal oral keratinocytes in response to chewing tobacco and cigarette smoke. Our results indicate that 
immortal oral keratinocytes treated with chewing tobacco or exposed to cigarette smoke show distinct altera-
tions in both miRNA and their protein targets. In addition, we have also identified a set of high confidence novel 
miRNAs in both tobacco treated and smoke exposed oral keratinocytes. Taken together, these findings imply 
that altered expression of miRNAs and their target proteins may be prominently involved in the initiation and 
progression of oral squamous cell carcinoma. Functional and clinical validation of this data is essential before 
these findings can be taken forward as potential diagnostic biomarkers in OSCC patients segregated based on the 
history of tobacco usage.
Materials and Methods
Cell culture. Human oral keratinocytes, OKF6/TERT1 cells were a generous gift from Dr. James Rheinwald 
(Brigham and Women’s Hospital, Boston, MA). OKF6/TERT1 cells are normal oral mucosal epithelial cells 
immortalized by hTERT72. OKF6/TERT1 were cultured and maintained in keratinocytes serum free medium 
(KSFM) supplemented with 1% penicillin/streptomycin, CaCl2 (0.4 mM), bovine pituitary extract (25 µg/ml) and 
epidermal growth factor (EGF) (0.2 ng/ml). Cells were grown at 37 °C in a humidified 5% CO2 incubator.
Treatment of OKF6/TERT1 cells with chewing tobacco extract and cigarette smoke conden-
sate. To study the chronic exposure effect of chewing tobacco, OKF6/TERT1 cells were treated with 1% 
chewing tobacco extract for a period of 6 months73. To study the chronic effect of cigarette smoke condensate 
(CSC Murty Pharmaceuticals, Inc, KY) OKF6/TERT1 cells were subjected to chronic exposure with 0.1% CSC 
in a smoke dedicated incubator for 6 months74. All cells were cultured for equal duration of time. Throughout 
the study, OKF6/TERT1 cells treated with chewing tobacco extract and cigarette smoke condensate have been 
referred to as “OKF6/TERT1-Tobacco” and “OKF6/TERT1-Smoke” cells, respectively. The parental control cells 
have been referred to as “OKF6/TERT1-Parental”.
Cell proliferation assays. OKF6/TERT1-Parental, OKF6/TERT1-Tobacco and OKF6/TERT1-Smoke cells 
were seeded at a density of 25 × 103 cells. Cellular proliferation was monitored for 6 days where the cells were 
counted every 48 h using trypan blue exclusion method. All assays were performed in replicates.
Western blotting. Cells were grown to 80% confluence and the proteins were harvested in RIPA lysis buffer 
(10 mM Tris pH 7.4, 150 mM NaCl, 5 mM EDTA, 1% Triton-X-100, 0.1% SDS containing protease and phos-
phatase inhibitor cocktails) and sonicated. Western blot analysis was carried out as described previously74 VIM 
antibody was obtained from Santa Cruz (Santa Cruz Biotechnology, Dallas, TX). Antibodies for E-cadherin were 
purchased from Cell Signaling (Cell Signaling Technology, Danvers, MA). SOD2 and TGFB2 antibodies were 
purchased from Cusabio (Baltimore Avenue, MD). β-actin antibody was procured from Sigma (Sigma Aldrich, 
USA) and was used as loading control.
Colony formation assays. Colony formation assays were carried out as described previously75.OKF6/
TERT1-Parental, OKF6/TERT1-Tobacco and OKF6/TERT1-Smoke cells were seeded at a cell density of 8.0 × 103 
cells per well in 6-well dishes. The colonies formed were fixed with methanol and stained with 4% methylene blue. 
Colonies formed was counted for ten randomly selected viewing fields and representative images were photo-
graphed at 3x magnification. All experiments were carried out in replicates.
Cell invasion assays. Invasion assays were performed in a transwell system (BD Biosciences) with 
Matrigel-coated filters, and cellular invasion was evaluated after 48 h as described previously75. Briefly, invasive-
ness of the cells was assayed in the membrane invasion culture system using polyethylene terephthalate (PET) 
membrane (8-μm pore size) in the upper compartment of a transwell coated with Matrigel (BD BioCoat Matrigel 
Invasion Chamber; BD Biosciences). The cells were seeded at 2.0 × 104 cells per 500 μl of serum free media on the 
Matrigel-coated PET membrane in the upper compartment. The lower compartment was filled with complete growth 
media and the plates were maintained at 37 °C for 48 h. At the end of the incubation time, the upper surface of the 
membrane was wiped with a cotton-tip applicator to remove non migratory cells. Cells that migrated to bottom side of 
membrane were fixed and stained using 4% methylene blue. The number of cells that penetrated was counted for ten 
randomly selected viewing fields at 10x magnification. All experiments were performed in triplicates.
RNA isolation and miRNA enrichment. Total RNA, including small RNA, was isolated using the Qiagen 
RNAeasy isolation kit from OKF6-TERT1-Parental, OKF6/TERT1-Tobacco and OKF6/TERT1-Smoke cells. The 
quantity and quality of RNA was analyzed on denaturing agarose gel as well as on Bioanalyzer RNA 6000 Pico 
chip. RNA isolated from each condition was used to construct sequencing libraries with the Illumina TruSeq 
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Small RNA Sample Prep Kit (Illumina, USA) as per manufacturer’s instructions. Briefly, 3′ and 5′ adapters were 
sequentially ligated to small RNA molecules and ligation products were subjected to reverse transcription to 
create single stranded cDNA. To selectively enrich fragments with adapter molecules on both ends, the cDNA 
was amplified with 50 PCR cycles using a common primer and a primer containing an index tag to allow sample 
multiplexing. The amplified cDNA constructs were gel purified, and validated by checking the size, purity, and 
concentration of the amplicons on the Agilent Bioanalyzer High Sensitivity DNA chip (#5067-4626, Genomics 
Agilent, Santa Clara, CA). The libraries were pooled in equimolar amounts, and sequenced on an Illumina HiSeq 
2500 instrument to generate 50-base pair reads.
miRNA sequencing and data analysis. The quality of the raw reads was checked using FASTQC (http://
www.bioinformatics.babraham.ac.uk/projects/fastqc) for OKF6/TERT1-Parental, OKF6/TERT1-Tobacco and 
OKF6/TERT1-Smoke samples. Cutadapt (http://cutadapt.readthedocs.io/en/stable/index.html) was used to 
remove low quality bases with Phred score ≤30 and adaptor sequences from 5′ and 3′ end of the read. The adap-
tor trimmed reads were aligned against nc-RNA sequence databases (GtRNA, piRNA, Rfam& snoRNA)76–79 
using Bowtie (version 1.1.2)80. Remaining reads were used for known miRNA identification. These reads were 
first aligned to mature and precursor sequence from miRBase 21 miRNA database (Human)81 using Bowtie. 
Unaligned reads were further aligned against human genome hg19 using miRDeep2 (version 2.0.0.6). Known 
miRNA that are quantified with at least 10 reads in both samples of a pairs i.e. OKF6/TERT1-Tobacco vs. OKF6/
TERT1-Parental and OKF6/TERT1-Smoke vs. OKF6/TERT1-Parental were further investigated for differential 
expression using DESeq82.
Novel miRNAs were assessed for the genomic location using UCSC BLAT83. They were also queried against 
database YM500V384 using ‘genomic location search’ option. YM500V3 is a repository of novel miRNA built using 
>8,000 smRNA data-sets pertaining to various cancers along with their CLIP-Seq results from different cell lines.
Sample preparation, in-solution digestion and TMT labelling. OKF6/TERT1-Parental, OKF6/
TERT1-Tobacco and OKF6/TERT1-Smoke cells were cultured and grown till 80% confluence. The cells were 
serum starved for 12 hours in ice-cold 1X PBS, lysed in 0.5% of SDS buffer followed by sonication (Branson 
Sonifier, Danbury, CT) and centrifugation. Supernatant was collected and protein estimation was carried out 
by using bicinchoninic acid assay (BCA)85. In-solution trypsin digestion of all three conditions was carried out 
as previously described86. Equal amounts of protein was taken from each condition, reduced using 5 mM dith-
iothreitol (DTT) and kept for incubation for 20 min at 60 °C. Alkylation was carried out using iodoacetamide 
(IAA) (20 mM) and incubated for 10 min in the dark at room temperature. The reduced and alkylated proteins 
were then precipitated using chilled acetone (1:5 v/v of sample) and incubated at −80 °C for 4–6 h to ensure 
complete removal of SDS from sample. Trypsin digestion was carried out at 37 °C for 12–16 h with an enzyme to 
substrate ratio of 1:50 (catalogue no. V5111; Promega). After trypsin digestion, the peptides were labelled with 
TMT reagents as per the manufacturer’s instructions. Briefly, peptide samples were dissolved in 50 mM TEABC 
(pH 8.0) and added to TMT reagents dissolved in anhydrous acetonitrile. Peptides from OKF6/TERT1-Parental 
cells and OKF6/TERT1-Tobacco were labelled with 126 and 129 C, respectively. In a separate experiment, OKF6/
TERT1-Parental cells and OKF6/TERT1-Smoke cells were labelled with 128 N and 129 C, respectively. After incu-
bation at room temperature for 1 h, the reaction was quenched with 5% hydroxylamine. The labelled samples 
from all conditions were pooled and subjected to fractionation.
Basic pH reverse-phase liquid chromatography. TMT labelled peptides were fractionated using a 
basic pH reverse HPLC system (Agilent,1290 series) by injecting 900 µL of the sample reconstituted in solvent A 
(10 mM TEABC in water; pH 8.5) on Xbridge (4.6 × 250 mm, 5 µm; Waters) column. The peptides were resolved 
by using a gradient of organic solvent; 2% solvent A (10 mM TEABC in water; pH 8.5) to 45% solvent B (10 mM 
TEABC in 90% acetonitrile, pH 8.5) over 100 min and further taken to 100% solvent B before coming back to 
2% solvent A for re-equilibration87. A total of 96 fractions were collected from 96-well plate, concatenated to 12 
fractions, and dried under vacuum for LC-MS2/MS3 analysis.
LC-MS2/MS3 analysis. Briefly all the 12 fractions were reconstituted in 0.1% formic acid and analyzed in trip-
licate on an Orbitrap Fusion Tribrid mass spectrometer (Thermo Scientific) that was interfaced with an Easy-nLC 
II nanoflow liquid chromatography system (Thermo Scientific). Peptides reconstituted in 0.1% formic acid were 
loaded onto a trap column that was packed (75 µm × 2 cm) with Magic C18 AQ (Michrom Bioresources, Inc.) at 
a flow rate of 300 nL/min. Peptides were separated on an analytical column (75 µm × 20 cm) at a flow rate of 300 
nL/min by using a linear gradient of 7–25% solvent B (0.1% formic acid in 95% acetonitrile) over 75 min which 
was increased to 35% for next 25 minutes. The total run time was set to 120 min and acquisition was carried out.
Data analysis. Proteome Discoverer (version 2.1.0.81) software suite (Thermo Fisher Scientific) was used 
for MS/MS searches using SEQUEST and Mascot (version 2.4.1; Matrix 617 Science) algorithms againt NCBI 
RefSeq human protein database (version 75 containing 36,709 protein sequences and known contaminants). The 
search parameters included trypsin as the protease with a maximum of 2 missed cleavages allowed; oxidation of 
methionine was set as a dynamic modification, carbamidomethylation of cysteine and TMT modification at pep-
tide N-terminus and lysine were set as static modifications. Precursor ion mass tolerance and fragment ion mass 
tolerance were allowed with 10 ppm and 0.05 Da, respectively and all the PSMs were identified with 1% FDR88. 
Proteins were identified at MS2 level and quantification was done at MS3 level.
Data availability. Raw sequencing data is available in SRA (Sequencing Read Archive) database with acces-
sion number PRJNA398169.
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